02.02.25 Study: Most people quit GLP-1 drugs for weight loss within a year A study published in JAMA Network Open found that 65% of people using GLP-1 drugs for weight loss quit taking them within a year
GLP-1s show promise in reducing nerve inflammation and cell death while supporting nerve health
To further validate the synergistic effects of multi-strain probiotics, a randomized double-blind placebo-controlled trial involving 104 women with PCOS was conducted over six months, employing a formulation combining seven probiotic strains ( Lactobacillus acidophilus UBLA-34, Lactobacillus rhamnosus UBLR-58, etc.) with fructooligosaccharides, alongside dietary and lifestyle modifications
We look beyond symptoms to understand why your nervous system is responding the way it is
While they may look flawless on screen, celebrities even Victoria Secret models have all types of skin conditions, including deep stretch marks caused by weight fluctuations and pregnancy
The STEER study aimed to assess the real-world incidence of major adverse cardiovascular events (MACE) during treatment with semaglutide or tirzepatide for chronic weight management in the United States, she said